PatientsVille.com Logo

Avastatin Side Effects

PatientsVille

Common Avastatin Side Effects


The most commonly reported Avastatin side effects (click to view or check a box to report):

Diarrhoea (1)
Endocarditis (1)
Groin Abscess (1)
Death (1)
Confusional State (1)
White Blood Cell Count Decreased (1)
Blood Pressure Increased (1)
Chills (1)
Haemoglobin Decreased (1)
Incoherent (1)
Pulmonary Embolism (1)
Stomatitis (1)
Vasculitis (1)
Neutropenia (1)
Nausea (1)
Intestinal Obstruction (1)
Lower Gastrointestinal Haemorrhage (1)
Blood Pressure Fluctuation (1)


If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Avastatin Side Effects Reported to FDA



Avastatin Side Effect Report#9053592
This is a report of a 87-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: NA, who was treated with Avastatin (dosage: 1 Every Six Weeks Intraoctular, start time:
Mar 18, 2009), combined with: NA. and developed a serious reaction and side effect(s): after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Avastatin treatment in male patients, resulting in Death side effect.
Avastatin Side Effect Report#7421194-X
White Blood Cell Count Decreased, Groin Abscess, Haemoglobin Decreased, Blood Pressure Increased
This report suggests a potential Avastatin (bevacizumab) (bevacizumab) White Blood Cell Count Decreased side effect(s) that can have serious consequences. A 43-year-old female patient (weight: NA) from United States was diagnosed with the following symptoms/conditions: neoplasm and used Avastatin (bevacizumab) (bevacizumab) (dosage: 1088 Mg) starting
Jan 06, 2011. After starting Avastatin (bevacizumab) (bevacizumab) the patient began experiencing various side effects, including: White Blood Cell Count Decreased, Groin Abscess, Haemoglobin Decreased, Blood Pressure IncreasedAdditional drugs used concurrently:
  • Carboplatin (900 Mg)
  • Abraxane (185 Mg, Intravenous)
The patient was hospitalized. Although Avastatin (bevacizumab) (bevacizumab) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as White Blood Cell Count Decreased, may still occur.
Avastatin Side Effect Report#7078413-1
Blood Pressure Fluctuation, Nausea
This Blood Pressure Fluctuation problem was reported by a health professional from United States. A 49-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: colorectal cancer metastatic. On NS this consumer started treatment with Avastatin Not Provided (dosage: NA). The following drugs were being taken at the same time:
  • Fluorouracil
When using Avastatin Not Provided, the patient experienced the following unwanted symptoms/side effects: Blood Pressure Fluctuation, NauseaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Blood Pressure Fluctuation, may become evident only after a product is in use by the general population.
Avastatin Side Effect Report#5723330-X
Intestinal Obstruction
This Intestinal Obstruction side effect was reported by a health professional from United States. A 63-year-old female patient (weight:NA) experienced the following symptoms/conditions: ovarian cancer.The patient was prescribed Avastatin(bevacizumab) Powder And Solvent For Solution For Infusion, 1 (drug dosage: NA), which was initiated on NS. Concurrently used drugs: NA..After starting to take Avastatin(bevacizumab) Powder And Solvent For Solution For Infusion, 1 the consumer reported adverse symptoms, such as: Intestinal ObstructionThese side effects may potentially be related to Avastatin(bevacizumab) Powder And Solvent For Solution For Infusion, 1.
Avastatin Side Effect Report#5723204-4
Neutropenia, Stomatitis
This is a report of a 43-year-old female patient (weight: NA) from United States, suffering from the following health symptoms/conditions: neuroendocrine carcinoma, who was treated with Avastatin(bevacizumab) Powder And Solvent For Solution For Infusion, 1 (dosage: 5 Mg/kg, Intravenous, start time: NS), combined with:
  • Fluorouracil (400 Mg/m2, Intravenous)
  • Doxorubicin Hcl (40 Mg/m2, Intravenous)
  • Streptozocin(streptozocin) (400 Mg/m2, Intravenous)
  • Protonix
and developed a serious reaction and side effect(s): Neutropenia, Stomatitis after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Avastatin(bevacizumab) Powder And Solvent For Solution For Infusion, 1 treatment in female patients, resulting in Neutropenia side effect. The patient was hospitalized.
Avastatin Side Effect Report#5723186-5
Pulmonary Embolism
This report suggests a potential Avastatin(bevacizumab) Powder And Solvent For Solution For Infusion, 1 Pulmonary Embolism side effect(s) that can have serious consequences. A 37-year-old female patient (weight: NA) from United States was diagnosed with the following symptoms/conditions: ovarian cancer and used Avastatin(bevacizumab) Powder And Solvent For Solution For Infusion, 1 (dosage: NA) starting NS. After starting Avastatin(bevacizumab) Powder And Solvent For Solution For Infusion, 1 the patient began experiencing various side effects, including: Pulmonary EmbolismAdditional drugs used concurrently: NA. Although Avastatin(bevacizumab) Powder And Solvent For Solution For Infusion, 1 demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pulmonary Embolism, may still occur.
Avastatin Side Effect Report#5723137-3
Lower Gastrointestinal Haemorrhage
This Lower Gastrointestinal Haemorrhage problem was reported by a physician from United States. A 53-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: colon cancer. On
Feb 01, 2007 this consumer started treatment with Avastatin(bevacizumab) Powder And Solvent For Solution For Infusion, 1 (dosage: 400 Mg, Q14d, Intravenous). The following drugs were being taken at the same time:
  • Oxaliplatin
  • Fluorouracil
  • Synthroid
When using Avastatin(bevacizumab) Powder And Solvent For Solution For Infusion, 1, the patient experienced the following unwanted symptoms/side effects: Lower Gastrointestinal HaemorrhageThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Lower Gastrointestinal Haemorrhage, may become evident only after a product is in use by the general population.
Avastatin Side Effect Report#4594085-X
Chills, Confusional State, Diarrhoea, Endocarditis, Incoherent, Vasculitis
This Chills side effect was reported by a physician from . A 67-year-old male patient (weight:NA) experienced the following symptoms/conditions: metastatic renal cell carcinoma.The patient was prescribed Avastatin (bevacizumab) (drug dosage: 10 Mg/kg , Q2w, Intravenous), which was initiated on
Jan 11, 2005. Concurrently used drugs:
  • Flomax
  • Ditropan
  • Calcium (calcium Nos)
  • Iron (iron Nos)
  • Multivitamin (multivitamins Nos)
  • Zometa
  • Tarceva
  • Atenolol
.After starting to take Avastatin (bevacizumab) the consumer reported adverse symptoms, such as: Chills, Confusional State, Diarrhoea, Endocarditis, Incoherent, VasculitisThese side effects may potentially be related to Avastatin (bevacizumab).


The appearance of Avastatin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.


Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Avastatin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Avastatin Side Effects

    Did You Have a Avastatin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Avastatin for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Avastatin Safety Alerts, Active Ingredients, Usage Information

    NDC0093-0771
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NamePravastatin Sodium
    NamePravastatin Sodium
    Dosage FormTABLET
    RouteORAL
    On market since20060425
    LabelerTeva Pharmaceuticals USA Inc
    Active Ingredient(s)PRAVASTATIN SODIUM
    Strength(s)10
    Unit(s)mg/1
    Pharma ClassHMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

    More About Avastatin

    Side Effects reported to FDA: 8

    Avastatin safety alerts: No

    Reported deaths: 1

    Reported hospitalizations: 2

    Latest Avastatin clinical trials